1.
Dr Absar Khalid Mir, Dr Mohammad Ahmad Abbasi, Dr Laiba Mustansar Sahi, Dr Samana Batool, Dr Muhammad Bilal Anwar, Dr Tehreem Ali, et al. EVALUATING THE RISK-BENEFIT PROFILE OF RIVAROXABAN VERSUS WARFARIN IN STROKE PREVENTION AMONG ELDERLY PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION; A RETROSPECTIVE COHORT STUDY. J Popl Ther Clin Pharmacol [Internet]. 2024 Jun. 12 [cited 2024 Dec. 21];31(6):1059-65. Available from: https://mail.jptcp.com/index.php/jptcp/article/view/6611